These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8794899)
21. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C. Lee JW; Joshi S; Chan JS; Wong YH J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309 [TBL] [Abstract][Full Text] [Related]
22. Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference. Suzuki T; Funada M; Narita M; Misawa M; Nagase H Eur J Pharmacol; 1991 Nov; 205(1):85-8. PubMed ID: 1667384 [TBL] [Abstract][Full Text] [Related]
23. Pertussis toxin pretreatment antagonizes the actions of mu- and delta-opiate agonists in hippocampal slices. Dunwiddie TV; Su MT Neurosci Lett; 1988 Dec; 95(1-3):329-34. PubMed ID: 2852323 [TBL] [Abstract][Full Text] [Related]
24. kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Smith JA; Loughlin SE; Leslie FM Mol Pharmacol; 1992 Oct; 42(4):575-83. PubMed ID: 1359395 [TBL] [Abstract][Full Text] [Related]
25. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells. Crain SM; Shen KF Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733 [TBL] [Abstract][Full Text] [Related]
26. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042 [TBL] [Abstract][Full Text] [Related]
27. mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Laugwitz KL; Offermanns S; Spicher K; Schultz G Neuron; 1993 Feb; 10(2):233-42. PubMed ID: 8382499 [TBL] [Abstract][Full Text] [Related]
28. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. Rady JJ; Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196 [TBL] [Abstract][Full Text] [Related]
29. Partial agonistic activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic acids in Chinese hamster ovary cells. Fukuda K; Kato S; Shoda T; Morikawa H; Mima H; Mori K Anesth Analg; 1998 Aug; 87(2):450-5. PubMed ID: 9706949 [TBL] [Abstract][Full Text] [Related]
30. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Chakrabarti S; Yang W; Law PY; Loh HH Mol Pharmacol; 1997 Jul; 52(1):105-13. PubMed ID: 9224819 [TBL] [Abstract][Full Text] [Related]
31. mu-Opioid receptor stimulation of inositol (1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein. Smart D; Smith G; Lambert DG J Neurochem; 1994 Mar; 62(3):1009-14. PubMed ID: 8113787 [TBL] [Abstract][Full Text] [Related]
32. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma. Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909 [TBL] [Abstract][Full Text] [Related]
33. Evidence for transduction of mu but not kappa opioid modulation of extracellular signal-regulated kinase activity by G(z) and G(12) proteins. Belcheva MM; Wong YH; Coscia CJ Cell Signal; 2000 Jul; 12(7):481-9. PubMed ID: 10989284 [TBL] [Abstract][Full Text] [Related]
34. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676 [TBL] [Abstract][Full Text] [Related]
35. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363 [TBL] [Abstract][Full Text] [Related]
36. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Bart G; Schluger JH; Borg L; Ho A; Bidlack JM; Kreek MJ Neuropsychopharmacology; 2005 Dec; 30(12):2254-62. PubMed ID: 15988468 [TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of delta-selectivity of indole analogs of nonpeptide opioids. Maguire PA; Perez JJ; Tsai NF; Rodriguez L; Beatty MF; Villar HO; Kamal JJ; Upton C; Casy AF; Loew GH Mol Pharmacol; 1993 Dec; 44(6):1246-51. PubMed ID: 8264562 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of exocrine pancreatic secretion by opiates is mediated by suppression of cholinergic transmission: characterization of receptor subtypes. Louie DS; Chen HT; Owyang C J Pharmacol Exp Ther; 1988 Jul; 246(1):132-6. PubMed ID: 2455787 [TBL] [Abstract][Full Text] [Related]
39. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
40. Augmenting effect of opioids on nitrite production by stimulated murine macrophages. Kowalski J Neuropeptides; 1998 Jun; 32(3):287-91. PubMed ID: 10189065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]